Let-7 employs its antiproliferative activities and its tumor-suppressor role by controlling key checkpoints of several mitogenic pathways and by suppressing different oncogenes, including HMGA2, RAS, and MYC [23,24]. The gene discussed is MYC; the disease is neoplasm.